The device is designed to lower blood pressure while simultaneously modulating the autonomic nervous system by delivering ...

The BACKBEAT global pivotal study is underway ... hypertension who are also indicated for a pacemaker. MODERATO II, a double-blind, randomized pilot study, showed that patients treated with ...

The BACKBEAT pivotal study is enrolling pacemaker ... hypertension who are also indicated for a pacemaker. MODERATO II, a double-blind, randomized pilot study, showed that patients treated with ...

MODERATO II, a double-blind, randomized pilot study ... demonstrate improvements in cardiac function and hemodynamics. The BACKBEAT (BradycArdia paCemaKer with atrioventricular interval modulation ...

So where does a midrange brand like Plantronics fit in among those big hitters? The $99 Plantronics BackBeat Fit 500 headphones are a great compromise between cost, performance, and style.

A Vision for the Future Orchestra BioMed is now advancing its investigation of AVIM therapy through the ongoing BACKBEAT ...

"We remain highly focused on execution of the BACKBEAT global pivotal study, which we believe has the potential to deliver landmark results that can establish AVIM therapy as a new standard of ...

Breakthrough Device Designation (“BDD”) applies to an estimated U.S. population of over 7.7 million patients with uncontrolled hypertension and increased cardiovascular risk BDD also encompasses ...

FDA recently granted Breakthrough Device Designation to AVIM therapy for use in patients with uncontrolled hypertension at increased cardiovascular riskHRS Satellite Symposium will feature leading ...